Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ABCELLERA BIOLOGICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 7.9M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $26.9M as of 2025-Q4. This is a new position. ABCL represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$26.9M
Current Shares
7.9M
Total Value Change
+$13.3M
Total Shares Change
+3.3M
Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors
New |
| 7.9M |
- |
| $26.9M |
| 0.0% |
| $3.45 |
40 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $4.87 | 0 |
| 2025-Q2 | Decreased | 8.5M | -45.9% | $29.1M | 0.0% | $3.61 | 0 |
| 2025-Q1 | Increased | 15.7M | +248.3% | $34.9M | 0.0% | $2.31 | 47 |
| 2024-Q4 | Decreased | 4.5M | -2.0% | $13.2M | 0.0% | $2.82 | 0 |
| 2024-Q3 | Decreased | 4.6M | -0.2% | $11.9M | 0.0% | $2.61 | 0 |
| 2024-Q2 | New | 4.6M | - | $13.6M | 0.0% | $2.96 | 39 |